Dental implant and bone augmentation treatment in bone-compromised patients: Oral health-related quality of life outcomes.
Dental implant and bone augmentation treatment in bone-compromised patients: Oral health-related quality of life outcomes.
复制标题
骨受损患者的牙种植体和骨增量治疗：口腔健康相关的生活质量结果。
DOI：
10.1016/j.prosdent.2023.01.011
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Freilich,Martin
中科院分区：
文献类型：
--
作者：
Leonard,JonathanF;Taxel,Pamela;Kuo,Chia-Ling;DaCunhaGodoy,Lucas;Freilich,Martin
问题陈述患者报告的结果代表了牙科种植体和骨增强治疗的一个额外的和经常被忽视的措施。很少有种植体研究评价患者报告的结果在那些全身骨compromis.PurposeThe的目的，这项队列研究的目的是评估口腔健康相关的生活质量（OHRQoL）的结果在绝经后妇女接受牙种植体与正常骨密度或轻度骨质疏松症（“健康”组;股骨颈、全髋关节和L1-L4脊柱的所有DXA T评分>-2.0）与中度骨量减少或骨质疏松症（“骨受损”组;股骨颈、全髋或L1-L4脊柱的任何DXA T评分≤-2.0）材料和方法作为标准护理、前瞻性、非随机队列研究的一部分，在康涅狄格大学牙科医学院共招募了115名患者。所有受试者均接受了3例骨增强手术中的1例植入种植体。在基线和种植体植入后的不同时间点，通过使用口腔健康影响概况-14（OHIP-14）和患者期望和满意度调查来测量OHRQoL。这些措施之间进行了比较健康和骨受损组（α= 0.05）。结果对于所有OHRQoL措施跨越线性混合效应模型，没有显着差异，发现骨组之间在基线和植入后的每个时间点（P> 0.05）。使用OHIP-14的最小重要差异（MID），在所有植入后时间点，骨组之间的患者结局没有明确的临床差异（P> 0.05）。从基线到种植体植入后24个月，健康组和骨受损组在OHIP-14和患者期望评分方面均表现出显著改善（P<0.05）。虽然没有组内差异，发现在患者满意度评分，平均满意度评分仍然很高，随着时间的推移，在两个group. ConclusionsPatient报告的结果，通过OHIP-14，患者的期望，和患者满意度调查表明类似的植入后OHRQoL改善健康和骨受损的个人。骨组之间的OHRQoL改善在连续性和范围上均相似，在种植体植入后24个月时，所有测量结果均无统计学显著性评分差异的证据，并且在所有时间点均无通过OHIP-14 MID比较测量的临床差异的明确证据。
Statement of problemPatient-reported outcomes represent an additional and often overlooked measure of dental implant and bone augmentation treatment. Few implant studies have evaluated patient-reported outcomes in those with systemic bone compromise.PurposeThe purpose of this cohort study was to assess oral health-related quality of life (OHRQoL) outcomes in postmenopausal women receiving dental implants with normal bone density or mild osteopenia (“healthy” group; all DXA T-scores at femoral neck, total hip, and L1-L4 spine>−2.0) versus moderate osteopenia or osteoporosis (“bone compromised” group; any DXA T-score at femoral neck, total hip, or L1-L4 spine≤−2.0).Material and methodsA total of 115 patients were recruited at the University of Connecticut School of Dental Medicine as part of a standard of care, prospective, nonrandomized cohort study. All participants received 1 of 3 bone augmentation procedures with implant placement. At baseline and at various intervals after implant placement, OHRQoL was measured by using the Oral Health Impact Profile-14 (OHIP-14) and surveys of patient expectations and satisfaction. These measures were compared between healthy and bone compromised groups (α=.05).ResultsFor all OHRQoL measures across linear mixed effects models, no significant differences were found between bone groups at baseline and at each time point after implant placement (P>.05). Using the minimally important difference (MID) for OHIP-14, no definitive clinical differences were found in patient outcomes between bone groups at all postimplant time points (P>.05). From baseline to 24 months after implant placement, both healthy and bone compromised groups exhibited significant improvements in OHIP-14 and patient expectations scores (P<.05). While no within group differences were found in patient satisfaction scores, the mean satisfaction score remained high over time in both groups.ConclusionsPatient-reported outcomes as measured through OHIP-14, patient expectations, and patient satisfaction surveys suggest similar postimplant OHRQoL improvement in healthy and bone compromised individuals. OHRQoL improvements between bone groups were similar both in continuity and in scope, with no evidence of statistically significant score differences between groups at 24 months after implant placement across all measures and with no definitive evidence of clinical differences as measured by OHIP-14 MID comparisons across all timepoints.